PRECISION ANTIGEN-DIRECTED IMMUNOTHERAPY TREATMENT OF BRAIN TUMORS INCREASES TUMOR-INFILTRATING EFFECTOR LYMPHOCYTE RESPONSES

被引:0
|
作者
Trivedi, Vrunda [1 ]
Yang, Changlin [1 ]
Yegorov, Oleg [1 ]
Klippel, Kelena [1 ]
Von Roemeling, Christina [1 ]
Hoang-Minh, Lan [1 ]
Fenton, Graeme [1 ]
Ogando-Rivas, Elizabeth [2 ]
Castillo, Paul [1 ]
Moore, Ginger [1 ]
Dyson, Kyle [1 ]
Mitchell, Duane [1 ]
机构
[1] Univ Florida, Gainesville, FL USA
[2] Boston Med Ctr, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMMU-33
引用
收藏
页数:1
相关论文
共 13 条
  • [1] Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
    Shuhang Wang
    Jingwei Sun
    Kun Chen
    Peiwen Ma
    Qi Lei
    Shujun Xing
    Zhongzheng Cao
    Shujun Sun
    Zicheng Yu
    Yarong Liu
    Ning Li
    BMC Medicine, 19
  • [2] Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
    Wang, Shuhang
    Sun, Jingwei
    Chen, Kun
    Ma, Peiwen
    Lei, Qi
    Xing, Shujun
    Cao, Zhongzheng
    Sun, Shujun
    Yu, Zicheng
    Liu, Yarong
    Li, Ning
    BMC MEDICINE, 2021, 19 (01)
  • [3] IMMUNOTHERAPY WITH A TUMOR-INFILTRATING LYMPHOCYTE CLONE, SOLUBLE-ANTIGEN, AND CYCLOPHOSPHAMIDE
    KOMICHI, H
    SMITH, S
    KAHAN, BD
    ARCHIVES OF SURGERY, 1992, 127 (12) : 1417 - 1423
  • [4] TREATMENT OF MURINE PRIMARY BRAIN-TUMORS WITH SYSTEMIC INTERLEUKIN-2 AND TUMOR-INFILTRATING LYMPHOCYTES
    SARIS, SC
    SPIESS, P
    LIEBERMAN, DM
    LIN, S
    WALBRIDGE, S
    OLDFIELD, EH
    JOURNAL OF NEUROSURGERY, 1992, 76 (03) : 513 - 519
  • [5] An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
    Ye, Kai
    Li, Fan
    Wang, Ruikun
    Cen, Tianyi
    Liu, Shiyu
    Zhao, Zhuoqian
    Li, Ruonan
    Xu, Lili
    Zhang, Guanmeng
    Xu, Zhaoyuan
    Deng, Li
    Li, Lili
    Wang, Wei
    Stepanov, Alexey
    Wan, Yajuan
    Guo, Yu
    Li, Yuanke
    Wang, Yuan
    Tian, Yujie
    Gabibov, Alexander G.
    Yan, Yingbin
    Zhang, Hongkai
    MOLECULAR THERAPY, 2022, 30 (12) : 3658 - 3676
  • [6] Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy
    Mehta, Apoorva
    Motavaf, Mateen
    Nebo, Ikenna
    Luyten, Sophia
    Osei-Opare, Kofi D.
    Gru, Alejandro A.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [7] Immunotherapy with tumor-infiltrating lymphocytes - An alternative in the therapy of solid tumors? A study about HER/2neu as a shared tumor-associated antigen in breast-, ovarian- and pancreatic cancer
    Peiper, M
    Goedegebuure, PS
    Broelsch, CE
    Eberlein, TJ
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1996, : 499 - 502
  • [8] Tumor-infiltrating B cells colocalize with CD4 T effector cells within tertiary lymphoid structures to present antigen and educate the antitumor immune response in human primary tumors
    Ruffin, Ayana T.
    Cillo, Anthony R.
    Kunning, Sheryl
    Ferris, Robert L.
    Vignali, Dario A. A.
    Bruno, Tullia C.
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 27 - 28
  • [9] Large established B16 tumors in mice are eradicated by ZVex® (dendritic cell-targeting lentiviral vector) and G100 (TLR4 agonist) combination immunotherapy through increasing tumor-infiltrating effector T cells and inducing antigen spreading
    Albershardt, Tina C.
    Parsons, Andrea J.
    Leleux, Jardin
    Berglund, Peter
    ter Meulen, Jan
    CANCER RESEARCH, 2017, 77
  • [10] Precision Cancer Immunotherapy: Optimizing Dendritic Cell-based Strategies to Induce Tumor Antigen-specific T-cell Responses Against Individual Patient Tumors
    Osada, Takuya
    Nagaoka, Koji
    Takahara, Masashi
    Yang, Xiao Yi
    Liu, Cong-Xiao
    Guo, Hongtao
    Choudhury, Kingshuk Roy
    Hobeika, Amy
    Hartman, Zachary
    Morse, Michael A.
    Lyerly, H. Kim
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (04) : 155 - 164